The pattern of long sideways periods will break in 2015 with the many upcoming catalysts.
At some point in 2015 the general market is going to recognize what CTIX has in Brilacidin alone. Trial results can't be ignored. The results will be recognized in 2015.
In Reply to 'BioHedge' Looks like everyone is taking an early thanksgiving. Low volume in the past few sessions. We look to be bouncing around the $2.8-$3.5 range till the next news hits.
I'll be fascinated to see how Leo manages the business in the short term. Science trumps and good execution trump everything else.
For those newly into CTIX in the $2s and $3s, those of us who've been in for some time know your pain. This is same pattern from 2012 and 2013. Short sprints higher with 10-20% retrenchments then long sideways movements. I expect that pattern to shorten with more sprints higher combined with shorter intervals of time between the sprints. There is much to like with CTIX but seeing one's paper wealth vary significantly is always hard (both on the ups and downs).
Building real wealth takes patience and discipline and is often not fun and not profitable for long stretches.